Ranbaxy Bows To Sweeping Penalties From US
The U.S. government on Wednesday sought court approval of a consent decree that will hold generic drug maker Ranbaxy Laboratories Ltd. to unprecedented standards before it can again produce drugs for...To view the full article, register now.
Already a subscriber? Click here to view full article